Join Jan B. Vermorken, MD, PhD as he shares some of the exciting updates on Squamous Cell Cancer of the Head & Neck (SCCHN).
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Current Updates on Squamous Cell Cancer of the Head and Neck (SCCHN)
Restart
Resume
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Comments
Overview
Learning Objectives
At the completion of this module, participants will be better able to:
- Understand the latest advances in preimplantation genetic screening/ diagnosis that will optimize fetal outcomes in ART
- Utilize appropriate screening and diagnostic protocols according to evidence-based guidelines, and incorporate latest technologies into clinical decision-making
Target Audience
The target audience for this activity includes Reproductive Endocrinologists, Embryologists, and Certified RE and Embryology Lab Technicians.
Accreditation and Credit Designation Statements
The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be available for immediate download.
Commercial Support
This activity is supported by an independent educational grant from Illumina, Inc.
Original Release Date: 29 March 2015
Expiration Date: 29 March 2016Provider(s)/Educational Partner(s)
Omnia Education has a core focus on women's health and the ways in which diseases and conditions impact the female patient. That unique focus has transformed the CME learning environment for healthcare professionals nationwide. We impact thousands of clinicians annually, many of whom return each year for clinical updates and connectivity with regional peers.
Contact Information
In case of technical needs, please contact: info@globalfertilityacademy.org
Disclosure of Conflicts of Interest
FACULTY
Robert E. Anderson, MD
Medical Director
Southern California Center for Reproductive Medicine
Newport Beach, CAFinancial Relationship Disclosure:
Consulting fees: Serono
Speaker: Illumina, Inc.Brian Kaplan, MD
Fertility Center of Illinois
Chicago, ILFinancial Relationship Disclosure:
Consulting fees: Actavis, Ferring, Good Start Genetics, SeronoMODERATOR
Michael J. Tucker, PhD, HCLD, FI Biol
IVF Laboratory Director
Shady Grove Fertility RSC
Rockville, MDFinancial Relationship Disclosure:
No relationships reportedREVIEWERS/PLANNERS/AUTHORS
Barry A. Fiedel, PhD
Financial Relationship Disclosure:
No relationships reportedAmanda Hilferty
Financial Relationship Disclosure:
No relationships reportedSean T. Saunders, CCMEP
Financial Relationship Disclosure:
No relationships reportedRobert Schneider
Financial Relationship Disclosure:
No relationships reportedLee Philip Shulman, MD, FACOG, FACMG
Financial Relationship Disclosure:
Consultant: Actavis, Bayer, Merck, Natera, Quest, Sequenom, Inc.
Speaker: Actavis, Bayer, Merck, Pfizer, Roche
Recommended
Details
Comments
Recommended
Overview
Join Jan B. Vermorken, MD, PhD as he shares some of the exciting updates on Squamous Cell Cancer of the Head & Neck (SCCHN).
Learning Objectives
At the completion of this module, participants will be better able to:
- Understand the latest advances in preimplantation genetic screening/ diagnosis that will optimize fetal outcomes in ART
- Utilize appropriate screening and diagnostic protocols according to evidence-based guidelines, and incorporate latest technologies into clinical decision-making
Target Audience
The target audience for this activity includes Reproductive Endocrinologists, Embryologists, and Certified RE and Embryology Lab Technicians.
Accreditation and Credit Designation Statements
The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be available for immediate download.
Commercial Support
This activity is supported by an independent educational grant from Illumina, Inc.
Original Release Date: 29 March 2015
Expiration Date: 29 March 2016Provider(s)/Educational Partner(s)
Omnia Education has a core focus on women's health and the ways in which diseases and conditions impact the female patient. That unique focus has transformed the CME learning environment for healthcare professionals nationwide. We impact thousands of clinicians annually, many of whom return each year for clinical updates and connectivity with regional peers.
Contact Information
In case of technical needs, please contact: info@globalfertilityacademy.org
Disclosure of Conflicts of Interest
FACULTY
Robert E. Anderson, MD
Medical Director
Southern California Center for Reproductive Medicine
Newport Beach, CAFinancial Relationship Disclosure:
Consulting fees: Serono
Speaker: Illumina, Inc.Brian Kaplan, MD
Fertility Center of Illinois
Chicago, ILFinancial Relationship Disclosure:
Consulting fees: Actavis, Ferring, Good Start Genetics, SeronoMODERATOR
Michael J. Tucker, PhD, HCLD, FI Biol
IVF Laboratory Director
Shady Grove Fertility RSC
Rockville, MDFinancial Relationship Disclosure:
No relationships reportedREVIEWERS/PLANNERS/AUTHORS
Barry A. Fiedel, PhD
Financial Relationship Disclosure:
No relationships reportedAmanda Hilferty
Financial Relationship Disclosure:
No relationships reportedSean T. Saunders, CCMEP
Financial Relationship Disclosure:
No relationships reportedRobert Schneider
Financial Relationship Disclosure:
No relationships reportedLee Philip Shulman, MD, FACOG, FACMG
Financial Relationship Disclosure:
Consultant: Actavis, Bayer, Merck, Natera, Quest, Sequenom, Inc.
Speaker: Actavis, Bayer, Merck, Pfizer, Roche
Facebook Comments